Board/Management Information • Nov 25, 2022
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6797H
Chariot Limited
25 November 2022

25 November 2022
Chariot Limited
("Chariot" or the "Company")
Change of Adviser
Chariot Limited, the Africa focused transitional energy group, announces that Stifel Nicolaus Europe Limited has been appointed as the Company's joint corporate broker with immediate effect, alongside Cenkos Securities plc, Chariot's existing Nominated Adviser and joint corporate broker.
Enquiries
| Chariot Limited Adonis Pouroulis, CEO Julian Maurice-Williams, CFO |
+44 (0)20 7318 0450 |
| Cenkos Securities Plc (Nomad and Joint Broker) Derrick Lee, Adam Rae (Corporate Finance) |
+44 (0)20 7397 8900 |
| Stifel Nicolaus Europe Limited (Joint Broker) Callum Stewart, Ashton Clanfield |
+44 (0) 20 7710 7760 |
| Celicourt Communications (Financial PR) Mark Antelme, Jimmy Lea |
+44 (0)20 8434 2754 |
NOTES FOR EDITORS:
About Chariot
Chariot is an African focussed transitional energy group with three business streams, Transitional Gas and Transitional Power and Green Hydrogen.
Chariot Transitional Gas is a high value, low risk gas development project offshore Morocco with strong ESG credentials in a fast-growing emerging economy with a clear route to early monetisation, delivery of free cashflow and material exploration upside.
Chariot Transitional Power is looking to transform the energy market in Southern Africa, providing a giant largely untapped market with cleaner, sustainable, and more reliable power.
Chariot Green Hydrogen is partnering with Total Eren and the Government of Mauritania on the potential development of a 10GW green hydrogen project, Project Nour. Further large-scale green hydrogen opportunities are also being evaluated.
The ordinary shares of Chariot Limited are admitted to trading on the AIM under the symbol 'CHAR'.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPBKPBQPBDDCDB
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.